Research programme: protein kinase inhibitors - ProQinase/ChemDiv
Latest Information Update: 04 Nov 2017
At a glance
- Originator ProQinase
- Developer ChemDiv; ProQinase
- Class
- Mechanism of Action Protein kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in Germany
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer in USA
- 18 Jul 2007 Preclinical development is ongoing